Skip to main content

MARSHALL WACE, LLP

Position in HIMS — Hims & Hers Health, Inc.

CIK 1318757 LONDON, X0

Position in HIMS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$146,229,981
+$131,195,029 QoQ
Shares Held
4,217,767
+482.4% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#11
of 507 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Derivatives in HIMS

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$8,518,614
PutShares
352,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. HIMS ranks #1 (24.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
This page
4,217,767 $146,229,981

All Filings in HIMS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $146,229,981 4,217,767
2026-03-31 $15,034,952 724,227
2025-12-31 $204,496 6,298
2025-06-30 $5,256,682 105,450
2025-03-31 $7,738,317 261,872
2024-12-31 $8,518,614 352,300
2024-12-31 $1,040,417 43,028
2024-09-30 $29,755,170 1,615,373
2024-06-30 $44,538,211 2,205,954
2024-03-31 $87,254,357 5,640,230
2023-12-31 $46,898,398 5,269,483
2023-09-30 $38,845,090 6,175,690
2023-06-30 $55,233,149 5,875,867
2023-03-31 $39,391,694 3,970,937
2022-12-31 $28,761,912 4,487,038
2022-09-30 $12,557,392 2,250,429
2022-06-30 $9,719,988 2,145,693
2022-03-31 $5,649,570 1,059,957
2021-12-31 $60,351 9,214
2021-09-30 $420,294 55,742
2020-12-31 $2,724,579 186,615